Xbrane Biopharma AB (publ) (STO:XBRANE)
Sweden
· Delayed Price · Currency is SEK 0.2235
-0.0080 (-3.46%)
Mar 28, 2025, 1:59 PM CET
Xbrane Biopharma AB Revenue
In the year 2024, Xbrane Biopharma AB had annual revenue of 198.72M SEK, down -16.76%. Xbrane Biopharma AB had revenue of 65.81M in the quarter ending December 31, 2024, a decrease of -1.62%.
Revenue
198.72M
Revenue Growth
-16.76%
P/S Ratio
1.32
Revenue / Employee
3.06M
Employees
65
Market Cap
327.12M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition